Skip to main content
    I

    Immutep Ltd ADR (IMMP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.21
    -0.17 (-5.03%)

    Market Cap: $24.91M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    67%(8/12)
    Avg Surprise
    +40.40%
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Aug 30
    		$N/AN/AN/ABeat-
    Dec 25
    Reported Feb 24
    		$-0.22$-0.20-9.90%Miss-984.0%
    Sep 25
    Reported Dec 3
    		$0.00$0.00N/ABeat-
    Jun 25
    Reported Aug 28
    		$-0.03N/A+80.20%Beat+83.0%
    Mar 25
    Reported May 28
    		$0.00$0.00N/ABeat-
    Dec 24
    Reported Feb 26
    		$-0.02N/A+85.71%Beat+88.9%
    Sep 24
    Reported Nov 27
    		$0.00$0.00N/ABeat-
    Jun 24
    Reported Aug 30
    		$-0.18$-0.13-33.16%Miss-19.2%
    Mar 24
    Reported Apr 29
    		$0.00$0.00N/ABeat-
    Dec 23
    Reported Feb 28
    		$-0.18$-0.13-40.73%Miss-16.6%
    Sep 23
    Reported Nov 29
    		$0.00$0.00N/ABeat-
    Jun 23
    Reported Sep 28
    		$-0.15$-0.16+7.38%Beat-
    Mar 23
    Reported May 31
    		$0.00$0.00N/ABeat-
    Dec 22
    Reported Feb 24
    		$-0.15$-0.16+3.26%Beat-
    Sep 22
    Reported Nov 30
    		$0.00$0.00N/ABeat-
    Jun 22
    Reported Jul 27
    		$0.00N/A+100.00%Beat-
    Mar 22
    Reported Jun 1
    		$0.00$0.00N/ABeat+100.0%
    Dec 21
    Reported Feb 22
    		$0.00N/A+100.00%Beat+100.0%
    Sep 21
    Reported Dec 1
    		$0.00$0.00N/ABeat+100.0%
    Jun 21
    Reported Aug 30
    		$0.00N/A+100.00%Beat+100.0%
    Mar 21
    Reported Jun 2
    		$-0.01$0.00N/AMiss+8.2%
    Dec 20
    Reported Feb 23
    		$-0.38$-0.36-5.56%Miss-6809.1%
    Sep 20
    Reported Dec 2
    		$-0.01$0.00N/AMiss-184.6%
    Jun 20
    Reported Aug 25
    		$-0.01$0.00N/AMiss-174.0%
    Mar 20
    Reported Jun 3
    		$-0.01$0.00N/AMiss+35.1%
    Dec 19
    Reported Feb 24
    		$-0.01$0.00N/AMiss+42.1%
    Sep 19
    Reported Nov 27
    		$-0.01$0.00N/AMiss+47.5%
    Jun 19
    Reported Aug 20
    		$-0.01$0.00N/AMiss+51.0%
    Mar 19
    Reported May 29
    		$-0.01$0.00N/AMiss+19.7%
    Dec 18
    Reported Feb 27
    		$-0.01$0.00N/AMiss+21.5%
    Sep 18
    Reported Nov 28
    		$-0.01$0.00N/AMiss-50.0%
    Jun 18
    Reported Aug 21
    		$-0.01$0.00N/AMiss-52.2%
    Mar 18
    Reported May 30
    		$-0.01$0.00N/AMiss+86.0%
    Dec 17
    Reported Feb 22
    		$-0.01$0.00N/AMiss-44.0%
    Sep 17
    Reported Dec 31
    		$-0.01$0.00N/AMiss-
    Jun 17
    Reported Aug 28
    		$-0.01$0.00N/AMiss-
    Mar 17
    Reported Jun 29
    		$-0.08$0.00N/AMiss-
    Dec 16
    Reported Feb 24
    		$-0.01N/A+97.67%Beat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-255.70%
    ROE-77.30%ROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage-1242.51x
    Current Ratio5.69xQuick Ratio5.69x
    Trading Statistics
    Beta2.30Avg Volume162.95K
    52-Week High$66.3952-Week Low$3.36

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.83
    SMA 20$4.51
    SMA 50$6.26
    SMA 200$20.07
    EMA 10$3.84
    EMA 20$4.50
    EMA 50$5.89
    EMA 200$15.64

    MACD

    Line: -0.86Signal: -0.81Hist: -0.05

    ADX

    ADX: 45.4+DI: 5.7-DI: 3.8

    Aroon & PSAR

    Aroon Up48.0
    Aroon Down44.0
    PSAR$1.44

    Bollinger Bands

    Upper Band$6.14
    Lower Band$2.88
    %B Position7244%(Upper)
    Band Width0.10

    RSI (14-Day)

    Oversold
    14.6

    Momentum Oscillators

    Stoch %K44.2
    Stoch %D58.2
    Williams %R-93.5
    ROC (10d)-29.3%
    Momentum-1.33
    CCI (20d)-20.9
    MFI (14d)20.7

    Volatility Measures

    ATR (14d)$2.45(76.4%)
    StdDev (20d)0.82
    Hist Vol48.4%(High)

    Volume Flow

    VWAP$3.20
    OBV748.4M
    AD Line1796856036086702.5B
    CMF (20d)447.591

    Volume Metrics

    Avg Vol (20d)154.1K
    Vol Ratio0.1x(Low)
    VWMA (20d)$5.33

    Pivot Points

    R3$3.67
    R2$3.61
    R1$3.49
    Pivot Point$3.43
    S1$3.31
    S2$3.25
    S3$3.13

    Advanced Oscillators

    TSI-62.23
    Ultimate Osc39.5
    KST-419.02

    Financial Data

    QuarterJun 2026Dec 2025Jun 2025Dec 2024Sep 2024Jun 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022
    Total Revenue$10.62M$6.03M$1.90M$3.15M$1.73M$1.73M$2.11M$1.82MN/AN/A$1.69M$170,369
    Cost of Revenue$1.07M$46.62M$36.08M$25.33M$21.11M$21.11M$995,788$924,019N/AN/A$935,195$1.12M
    Gross Profit$9.55M$-40,596,078$-34,183,766$-22,182,993$-19,379,132$-19,379,132$1.11M$896,169N/AN/A$750,339$-946,330
    Operating Expenses$49.10M$5.43M$40.49M$29.56M$25.16M$25.16M$25.24M$20.91MN/AN/A$22.17M$18.51M
    R&D$0$0$36.08M$25.33M$21.11M$21.11M$20.44M$9.82M$0$0$18.97M$10.71M
    SG&A$0$5.43M$4.41M$4.23M$4.05M$4.05M$4.80M$4.55M$0$0$4.13M$2.91M
    Operating Income$-39,547,735$-46,025,634$-74,674,496$-51,747,299$-44,539,830$-44,539,830$-43,564,356$-21,830,440N/AN/A$-23,106,590$-19,455,580
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$49,285$18,940$12,560$11,421$19,808$19,808$10,786$5,414$0$0$14,987$4,074
    Income Before Tax$-34,930,969$-44,859,721$-39,056,736$-22,377,429$-21,488,434$-21,488,434$-21,228,191$-19,273,098$0$0$-20,623,250$-15,940,613
    Income Tax Expense$0$0$0$0$21.11M$21.11M$2$1$0$0$-5$-18
    Net Income$-34,930,969$-44,859,721$-39,056,736$-22,377,429$-21,488,434$-21,488,434$-21,228,191$-19,273,098N/AN/A$-20,623,250$-15,940,613
    EBITDA$-38,473,108$-44,906,878$-37,427,669$-26,393,158$-22,298,635$-22,346,077$-22,112,872$-19,080,963N/AN/A$-20,452,782$-15,925,177
    EBIT$-39,547,734$-46,025,634$-38,594,627$-26,416,635$-23,429,564$-23,429,564$-23,127,898$-20,010,253$-10,005,127$-10,005,127$-21,421,052$-16,994,142
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about IMMP

    News

    Immutep Announces 2026 Annual General Meeting for November 27 with Director Nomination Deadline on October 23

    Immutep Limited (ASX:IMM) has announced its 2026 Annual General Meeting will be held on Friday, November 27, 2026, at 11:30 am AEDT. A Notice of Meeting, including the agenda and format...

    Kalkine Media•10/14/26•Neutral

    Monash secures another grant from the ARC to study the immune 'brake' behind Immutep's technologies

    Monash University has received a $652,248 grant from the Australian Research Council (ARC) to continue its research on Lymphocyte Activation Gene-3 (LAG-3)...

    BiotechDispatch•10/14/26•Bullish

    Immutep (IMMP) Gains A$652K ARC Grant to Advance LAG-3 Research Collaboration

    Immutep Ltd (IMMP) announced that Monash University received a A$652,248 grant from the Australian Research Council to fund a three-year research project on Lymphocyte Activation Gene-3 (LAG-3). This collaboration aims...

    GuruFocus•10/14/26•Neutral

    Immutep and Monash University Secure Further ARC Linkage Projects Funding for LAG-3 Research

    Immutep and Monash University have secured an Australian Research Council (ARC) grant of A$652,248 over three years to further their research collaboration on Lymphocyte Activation Gene-3 (LAG-3). The project...

    Stock Titan•10/14/26•Somewhat-Bullish

    Immutep and Monash University Secure Further ARC Linkage Projects Funding for LAG-3 Research

    Immutep Limited and Monash University have received additional funding from the Australian Research Council (ARC) for their collaborative research into Lymphocyte Activation Gene-3 (LAG-3). The A$652,248 grant over three...

    Yahoo Finance•10/14/26•Bullish

    IMMP Valuation and Fair Value

    Forward P/E
    7.1x
    P/B
    0.6x
    See GNG's fair value

    IMMP Profitability: Margins, ROIC and FCF

    Gross margin
    -180.1%
    Operating margin
    -255.7%
    Net margin
    0.0%
    ROE
    -77.3%
    FCF margin
    -1050.5%

    IMMP Competitors

    CompanyTicker
    Shuttle Pharmaceuticals IncSHPH
    Galecto IncGLTO
    Evaxion Biotech ASEVAX
    Context Therapeutics IncCNTX
    Polyrizon Ltd. Ordinary SharesPLRZ
    TherapeuticsMD IncTXMD
    Seres Therapeutics IncMCRB
    Heartbeam IncBEAT

    Sector: Healthcare

    IMMP Bull Case vs Bear Case

    Bull case

    • IMMP grew quarterly revenue 633.0% year over year.

    Bear case

    • IMMP beat EPS estimates in 25.0% of its last 8 reported quarters.

    IMMP Earnings: Beat Rate and Next Report

    Beat rate
    2 of 8 quarters (25.0%)
    Average surprise
    30.7%

    Frequently Asked Questions About IMMP

    Does IMMP pay dividends?

    Immutep Ltd ADR (IMMP) does not currently pay a regular dividend.

    What is IMMP's market cap?

    Immutep Ltd ADR (IMMP) has a market capitalization of $24.91M with a current stock price of $3.21.

    Related stocks

    Sector: Healthcare

    All stocks starting with I

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In